AU541679B2 – Ergolinyl -n:,n:-diethylurea derivatives
– Google Patents
AU541679B2 – Ergolinyl -n:,n:-diethylurea derivatives
– Google Patents
Ergolinyl -n:,n:-diethylurea derivatives
Info
Publication number
AU541679B2
AU541679B2
AU59135/80A
AU5913580A
AU541679B2
AU 541679 B2
AU541679 B2
AU 541679B2
AU 59135/80 A
AU59135/80 A
AU 59135/80A
AU 5913580 A
AU5913580 A
AU 5913580A
AU 541679 B2
AU541679 B2
AU 541679B2
Authority
AU
Australia
Prior art keywords
ergolinyl
diethylurea
derivatives
diethylurea derivatives
Prior art date
1979-06-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU59135/80A
Other versions
AU5913580A
(en
Inventor
Ulrich Eder
Reinhard Horowski
Wolfgang Kehr
Hans Peter Lorenz
Gerhard Sauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1979-06-13
Filing date
1980-06-09
Publication date
1985-01-17
1979-06-13
Priority claimed from DE19792924102
external-priority
patent/DE2924102A1/en
1980-04-28
Priority claimed from DE19803016691
external-priority
patent/DE3016691A1/en
1980-06-09
Application filed by Schering AG
filed
Critical
Schering AG
1980-12-18
Publication of AU5913580A
publication
Critical
patent/AU5913580A/en
1985-01-17
Application granted
granted
Critical
1985-01-17
Publication of AU541679B2
publication
Critical
patent/AU541679B2/en
2000-06-09
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
C07D457/12—Nitrogen atoms
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P25/00—Drugs for disorders of the nervous system
AU59135/80A
1979-06-13
1980-06-09
Ergolinyl -n:,n:-diethylurea derivatives
Ceased
AU541679B2
(en)
Applications Claiming Priority (4)
Application Number
Priority Date
Filing Date
Title
DE29241029
1979-06-13
DE19792924102
DE2924102A1
(en)
1979-06-13
1979-06-13
3-Ergolin-8-yl-1,1-di:ethyl-urea derivs. – useful as dopaminergic stimulants
DE30166917
1980-04-28
DE19803016691
DE3016691A1
(en)
1980-04-28
1980-04-28
8-Di:ethyl-ureido-ergoline derivs. – with dopaminergic activity
Publications (2)
Publication Number
Publication Date
AU5913580A
AU5913580A
(en)
1980-12-18
AU541679B2
true
AU541679B2
(en)
1985-01-17
Family
ID=25779537
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU59135/80A
Ceased
AU541679B2
(en)
1979-06-13
1980-06-09
Ergolinyl -n:,n:-diethylurea derivatives
Country Status (14)
Country
Link
US
(1)
US4379790A
(en)
EP
(1)
EP0021206B1
(en)
AU
(1)
AU541679B2
(en)
CA
(1)
CA1140922A
(en)
CS
(1)
CS223809B2
(en)
DD
(1)
DD151449A5
(en)
DE
(1)
DE3063869D1
(en)
DK
(1)
DK149059C
(en)
ES
(1)
ES8101073A1
(en)
HU
(1)
HU184786B
(en)
IE
(1)
IE49991B1
(en)
IL
(1)
IL60261A
(en)
SU
(1)
SU965356A3
(en)
YU
(1)
YU41929B
(en)
Cited By (1)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU589933B2
(en)
*
1984-12-24
1989-10-26
Sandoz Ltd.
8 alpha-acylaminoergoline, its production and pharmaceutical compositions containing it
Families Citing this family (22)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
CH654838A5
(en)
*
1980-07-25
1986-03-14
Sandoz Ag
ERGOLINDERIVATE, VERFAHREN ZU DEREN HERSTELLUNG, DIESE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN.
CH644606A5
(en)
*
1980-09-23
1984-08-15
Sandoz Ag
METHOD FOR ISOMERIZING 9,10-DIHYDROLYSE ENERGY DERIVATIVES.
DE3101535A1
(en)
*
1981-01-14
1982-08-12
Schering Ag, 1000 Berlin Und 4619 Bergkamen
NEW (2-HALOGEN-ERGOLINYL) -N’.N’-DIETHYL-UREA DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT
DE3135305C2
(en)
*
1981-09-03
1983-07-21
Schering Ag, 1000 Berlin Und 4619 Bergkamen
Process for the production of 8-ergolinyl ureas
DE3151912A1
(en)
*
1981-12-23
1983-06-30
Schering Ag, 1000 Berlin Und 4619 Bergkamen
NEW ERGOLIN AMINO DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS
CS231214B1
(en)
*
1982-03-12
1984-10-15
Antonin Cerny
Processing method of 1-substituted n+l8alpha-ergoline+p-n,diethyl urea
DE3216870A1
(en)
*
1982-05-03
1983-11-03
Schering AG, 1000 Berlin und 4709 Bergkamen
PHARMACEUTICAL PREPARATIONS WITH A CYTOSTATIC EFFECT
DE3309493A1
(en)
*
1983-03-14
1984-09-20
Schering AG, 1000 Berlin und 4709 Bergkamen
NEW ERGOLIN DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND USE AS A MEDICINAL PRODUCT
DE3445784A1
(en)
*
1984-12-13
1986-06-26
Schering AG, Berlin und Bergkamen, 1000 Berlin
METHOD FOR PRODUCING ERGOLIN DERIVATIVES
EP0208417A3
(en)
*
1985-06-12
1989-09-06
SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu
Use of 1-(8-alpha-ergolinyl)-3,3-diethyl urea derivatives in the treatment of endometritis
DE3522894A1
(en)
*
1985-06-24
1987-01-02
Schering Ag
USE OF TERGURID AS GERIATRIC
DE3528576A1
(en)
*
1985-08-06
1987-02-19
Schering Ag
METHOD FOR THE PRODUCTION OF ERGOLIN THIOUROS
DE3533672A1
(en)
*
1985-09-19
1987-03-26
Schering Ag
NEW 12- AND 13-SUBSTITUTED ERGOL DERIVATIVES
DE3533675A1
(en)
*
1985-09-19
1987-03-26
Schering Ag
NEW 12- AND 13-BROMINE ERGOL DERIVATIVES
DK338789A
(en)
*
1988-07-15
1990-01-16
Schering Ag
2-SUBSTITUTED ERGOLINYLURINE DERIVATIVES AND PROCEDURES FOR THE PRODUCTION THEREOF, THEIR USE AS MEDICINES AND INTERMEDIATES FOR THE PRODUCTION THEREOF
DE10043321B4
(en)
*
2000-08-24
2005-07-28
Neurobiotec Gmbh
Use of a transdermal therapeutic system for the treatment of Parkinson’s disease, for the treatment and prevention of premenstrual syndrome and for lactation inhibition
US20070243240A9
(en)
*
2000-08-24
2007-10-18
Fred Windt-Hanke
Transdermal therapeutic system
DE10053397A1
(en)
*
2000-10-20
2002-05-02
Schering Ag
Use of a dopaminergic active ingredient for the treatment of dopaminerg treatable diseases
DE10064453A1
(en)
*
2000-12-16
2002-07-04
Schering Ag
Use of a dopaminergic active ingredient for the treatment of dopaminerg treatable diseases
DE10226459A1
(en)
*
2002-06-13
2004-01-08
Neurobiotec Gmbh
Use of dopamine partial agonists to treat restless legs syndrome
GB0307377D0
(en)
*
2003-03-31
2003-05-07
Merad Pharmaceuticals Ltd
Ergoline derivatives
EP2083008A1
(en)
*
2007-12-07
2009-07-29
Axxonis Pharma AG
Ergoline derivatives as selective radical scavengers for neurons
Family Cites Families (7)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
DE1212097B
(en)
*
1962-09-05
1966-03-10
Sdruzeni Podnikuu Pro Zdravotn
Process for the preparation of N- [D-1, 6-dimethylisoergolenyl- (8)] – N ‘, N’-dialkylureas
CH430738A
(en)
*
1962-09-05
1967-02-28
Spofa Vereinigte Pharma Werke
Process for the preparation of N- (D-1,6-dimethyl-isoergolenyl-8) -N ‘, N’-dialkyl-ureas
US3681497A
(en)
*
1966-06-07
1972-08-01
Spofa Vereinigte Pharma Werke
Therapeutic methods of employing hydrogen maleate salt of n-(d-6-methyl-8-isoergolenyl)-n{40 ,n{40 -diethyl-carbamide
FR1536759A
(en)
*
1966-09-14
1968-08-16
Spofa Vereinigte Pharma Werke
Process for the preparation of n- / d-6-methyl-8-isoergolényl / -n ‘, n’-diethyl-urea
CH573936A5
(en)
*
1971-08-05
1976-03-31
Spofa Vereinigte Pharma Werke
US3920664A
(en)
*
1972-07-21
1975-11-18
Lilly Co Eli
D-2-halo-6-alkyl-8-substituted ergolines and related compounds
JPS5448880A
(en)
*
1977-09-02
1979-04-17
Tetra Pak Int
Method of designing packaging laminate and packaging laminate
1980
1980-06-07
DE
DE8080103177T
patent/DE3063869D1/en
not_active
Expired
1980-06-07
EP
EP80103177A
patent/EP0021206B1/en
not_active
Expired
1980-06-09
IL
IL60261A
patent/IL60261A/en
unknown
1980-06-09
AU
AU59135/80A
patent/AU541679B2/en
not_active
Ceased
1980-06-10
YU
YU1544/80A
patent/YU41929B/en
unknown
1980-06-11
DD
DD80221757A
patent/DD151449A5/en
not_active
IP Right Cessation
1980-06-12
DK
DK252680A
patent/DK149059C/en
not_active
IP Right Cessation
1980-06-12
CS
CS804168A
patent/CS223809B2/en
unknown
1980-06-12
CA
CA000353888A
patent/CA1140922A/en
not_active
Expired
1980-06-12
SU
SU802930703A
patent/SU965356A3/en
active
1980-06-12
HU
HU801488A
patent/HU184786B/en
not_active
IP Right Cessation
1980-06-12
IE
IE1210/80A
patent/IE49991B1/en
not_active
IP Right Cessation
1980-06-13
ES
ES492400A
patent/ES8101073A1/en
not_active
Expired
1982
1982-01-06
US
US06/337,355
patent/US4379790A/en
not_active
Expired – Fee Related
Cited By (1)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU589933B2
(en)
*
1984-12-24
1989-10-26
Sandoz Ltd.
8 alpha-acylaminoergoline, its production and pharmaceutical compositions containing it
Also Published As
Publication number
Publication date
SU965356A3
(en)
1982-10-07
ES492400A0
(en)
1980-12-16
ES8101073A1
(en)
1980-12-16
IL60261A
(en)
1983-10-31
YU154480A
(en)
1983-09-30
DE3063869D1
(en)
1983-07-28
US4379790A
(en)
1983-04-12
YU41929B
(en)
1988-02-29
HU184786B
(en)
1984-10-29
IE49991B1
(en)
1986-01-22
DD151449A5
(en)
1981-10-21
DK149059B
(en)
1986-01-06
CA1140922A
(en)
1983-02-08
DK252680A
(en)
1980-12-14
EP0021206A1
(en)
1981-01-07
AU5913580A
(en)
1980-12-18
CS223809B2
(en)
1983-11-25
IE801210L
(en)
1980-12-13
DK149059C
(en)
1986-07-14
IL60261A0
(en)
1980-09-16
EP0021206B1
(en)
1983-06-22
Similar Documents
Publication
Publication Date
Title
AU533566B2
(en)
1983-12-01
Aminoalkylbenzene derivatives
AU541679B2
(en)
1985-01-17
Ergolinyl -n:,n:-diethylurea derivatives
AU538841B2
(en)
1984-08-30
Quindine derivatives
AU542537B2
(en)
1985-02-28
Nor-tropane derivatives
AU547149B2
(en)
1985-10-10
3-aminopropoxy – indole derivatives
AU516325B2
(en)
1981-05-28
Spiro-imidazolidinedione derivatives
AU529742B2
(en)
1983-06-16
Alkyl-ketohexopyranoside derivatives
AU534806B2
(en)
1984-02-16
3-vinyl-cephalosporin derivatives
AU538138B2
(en)
1984-08-02
Methylene-cycloamine derivatives
AU533797B2
(en)
1983-12-08
Thioethylamide derivatives
AU520245B2
(en)
1982-01-21
Glycerylphosphoryl derivatives
AU526214B2
(en)
1982-12-23
Pteridin derivatives
AU6494680A
(en)
1981-06-11
2,3-indoledione derivatives
AU538139B2
(en)
1984-08-02
3-methyleneazetidine derivatives
AU530761B2
(en)
1983-07-28
Halo-vincamone derivatives
AU530398B2
(en)
1983-07-14
N-substituted-2,6-dimethylmorpholine derivatives
AU538087B2
(en)
1984-07-26
Halophenyl-pyridyl – allylamine derivatives
AU526584B2
(en)
1983-01-20
2,3-dicyanopyrazine derivatives
AU533484B2
(en)
1983-11-24
Tetrahydrochinoline derivatives
AU538028B2
(en)
1984-07-26
1-oxadethiacephalosporin derivatives
AU535388B2
(en)
1984-03-15
1-substituted-3-cycloalkyl-sulphonyl-pyrrolidine-2,5-dione derivatives
AU515140B2
(en)
1981-03-19
2, 4, 7-triamino-pteridine derivatives
AU518068B2
(en)
1981-09-10
15-sulfonamidoprostaglandin derivatives
AU534308B2
(en)
1984-01-19
15-hydroxyimino-e-homo-eburnane derivatives
AU529072B2
(en)
1983-05-26
25-hydroxycholecalciferol-26,23-lactone
None